Prudential Financial Inc Sesen Bio, Inc. Transaction History

Prudential Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.89 $4,438 - $10,395	-11,680 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.58 - $0.86 $391,384 - $580,328	-674,800 Reduced 98.3%	11,680 $7,000
Q4 2021 Feb 14, 2022	BUY	$0.73 - $1.28 $491,801 - $862,336	673,700 Added 5271.52%	686,480 $559,000
Q3 2021 Nov 15, 2021	BUY	$0.77 - $4.91 $1,593 - $10,163	2,070 Added 19.33%	12,780 $10,000
Q2 2021 Aug 16, 2021	BUY	$2.18 - $4.66 $23,347 - $49,908	10,710 New	10,710 $49,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.